Showing 1,523 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

New & experimental HIV treatments

Will Germany Squelch Gilead Hopes For Its Stribild AIDS Drug?

Editor's pick
Pharmalot
19 September 2013
TB treatment

2013 Tuberculosis Medicines Technology and Market Landscape

Editor's pick
UNITAID
17 September 2013
PrEP science

US PrEP prescriptions more likely to go to Southern women

News
13 September 2013
Global health initiatives

UNITAID wooing India to become contributing member

Editor's pick
PharmBiz
13 September 2013
Hepatitis B

Medivir and Daewoong pull plug on hepatitis B drug

Editor's pick
PharmaTimes
6 September 2013
Bad science & bogus treatments

Cameroonians ‘Dying’ for Fake Drugs

Editor's pick
Inter Press Service
5 September 2013
New & experimental hepatitis C treatment

Merck demand triggers expanding patent war with Gilead over sofosbuvir

Editor's pick
FierceBiotech
2 September 2013
Pharmaceutical industry

ViiV goes for gold: US premium pricing may threaten dolutegravir use in Europe

Editor's pick
HIV i-Base
19 August 2013
Access to healthcare

Medicines Patent Pool Is 'Taken Seriously' Now: Perry Explains

Editor's pick
Pharmalot
15 August 2013
New & experimental HIV treatments

ViiV's newly minted HIV fighter Tivicay to cost $14K per year

Editor's pick
Fierce Pharma
14 August 2013
New & experimental HIV treatments

FDA approves new drug to treat HIV infection

Editor's pick
FDA
13 August 2013
Access to healthcare

HIV Survivors Seek Drug Advances as FDA Eases Approvals

Editor's pick
Bloomberg
12 August 2013
Access to healthcare

Roche and the Medicines Patent Pool Sign Agreement to Increase Access to Medicines to Treat CMV infection in HIV-patients, a major cause of Blindness

Editor's pick
Roche press release
5 August 2013
Pharmaceutical industry

China Revokes Viread Patent; Pricing Was at Issue

Editor's pick
Bioworld.com
5 August 2013
Pharmaceutical industry

Gilead profit up 8.6% on sales growth of HIV drugs - MarketWatch

Editor's pick
Google Alerts HIV
26 July 2013
Activism & civil society

EATG statement: Big pharma mobilising patients in battle over drugs trials data

Editor's pick
EATG
22 July 2013
New & experimental hepatitis C treatment

How to Save $200 Billion and Cure Hepatitis C

Editor's pick
Xconomy
22 July 2013
Pharmaceutical industry

Big pharma mobilising patients in battle over drugs trials data

Editor's pick
The Guardian
22 July 2013
Drug-resistant TB

Sequella nabs rights to Pfizer tuberculosis antibiotic

Editor's pick
Washington Business Journal (blog)
19 July 2013
Pharmaceutical industry

FDA: Are drugmakers following through on post-marketing commitments?

Editor's pick
Pharmalot
15 July 2013
Health monitoring in resource-limited settings

Zyomyx lines up hand-held HIV test deal with Mylan

Editor's pick
San Francisco Business Times
11 July 2013
Access to healthcare

Non-African middle-income countries pay four times more for ARVs than African middle-income countries

News
9 July 2013
Access to healthcare

The Medicines Patent Pool Welcomes New WHO Treatment Guidelines

Editor's pick
Medicines Patent Pool
1 July 2013
Access to healthcare

2013 Pipeline Report calls on leaders to get the best HIV, hepatitis C virus (HCV), and tuberculosis drugs, diagnostics, and vaccines to the most people as quickly as possible

Editor's pick
Treatment Action Group
30 June 2013